Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENDO INTERNATIONAL PLC

(ENDP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Endo: Q1 Earnings Snapshot

05/06/2021 | 07:14pm EDT

DUBLIN (AP) _ Endo International PLC (ENDP) on Thursday reported first-quarter earnings of $41.5 million.

On a per-share basis, the Dublin-based company said it had profit of 17 cents. Earnings, adjusted for one-time gains and costs, were 73 cents per share.

The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 48 cents per share.

The health care company posted revenue of $717.9 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $670.5 million.

Endo expects full-year earnings in the range of $1.95 to $2.30 per share, with revenue in the range of $2.65 billion to $2.79 billion.

Endo shares have declined 24% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.43, an increase of 30% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENDP at https://www.zacks.com/ap/ENDP

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about ENDO INTERNATIONAL PLC
07/29ENDO INTERNATIONAL : Presents New Investigational Collagenase Clostridium Histol..
AQ
07/29Endo International plc Presents New Investigational Collagenase Clostridium H..
CI
07/22ENDO INTERNATIONAL : Reaches Agreement in Principle to Settle Opioid-Related Cas..
MT
07/22ENDO INTERNATIONAL : Drugmaker Endo settles opioid claims by Tennessee counties,..
RE
07/22ENDO INTERNATIONAL : Drugmaker Endo settles opioid claims by Tennessee counties,..
RE
07/22ENDO INTERNATIONAL : Announces Agreement in Principle to Settle Tennessee State ..
AQ
07/21FACTBOX-Companies pay billions of dollars over role in U.S. opioid crisis
RE
07/21Drugmakers, pharmacies next targets for U.S. opioid settlements
RE
07/20New York, drug distributors reach $1.18 billion opioid settlement as national..
RE
07/20MARKET CHATTER : Endo Pharmaceuticals Soars After Drug Maker Reportedly Proposes..
MT
More news
Financials (USD)
Sales 2021 2 728 M - -
Net income 2021 122 M - -
Net Debt 2021 6 743 M - -
P/E ratio 2021 4,52x
Yield 2021 -
Capitalization 1 181 M 1 181 M -
EV / Sales 2021 2,90x
EV / Sales 2022 2,77x
Nbr of Employees 3 397
Free-Float 98,5%
Chart ENDO INTERNATIONAL PLC
Duration : Period :
Endo International plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ENDO INTERNATIONAL PLC
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 5,06 $
Average target price 7,63 $
Spread / Average Target 50,7%
EPS Revisions
Managers and Directors
Blaise A Coleman President, Chief Executive Officer & Director
Mark Bradley Chief Financial Officer & Executive Vice President
Mark G. Barberio Chairman
Ruth Thorpe Chief Information Officer
Robert Polke Global Head-Operations